The impact of asthma and asthma-like illness in Seattle school children

被引:35
作者
Maier, WC
Arrighi, HM
Morray, B
Llewllyn, C
Redding, GJ
机构
[1] Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
[3] Childrens Hosp, Seattle, WA USA
[4] Univ Washington, Sch Med, Seattle, WA USA
关键词
childhood asthma; health services research; epidemiology;
D O I
10.1016/S0895-4356(98)00027-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The impact of asthma and asthma-like illness was measured in a population of 5-9-year-old Seattle public school children. Child health information was obtained from a survey of 1665 parents of first and second grade students to assess medical services use and impaired physical functioning among diagnosed asthmatics and those with current wheezing, defined as wheezing in the past 12 months without a diagnosis of asthma, relative to an asymptomatic population with neither condition. Relative to the asymptomatic population, the prevalence of respiratory-related activity limitation, and perception of poorer child health was larger among diagnosed asthmatics than children with current wheezing. However, the prevalence of sleep disturbances, school absences, medical services use, and parental concern over their child's health was similar for both the asthmatic and wheezing groups relative to the asymptomatic group. Also, in both symptomatic groups, a history of moderate or severe wheezing was associated with an increased prevalence of respiratory-related sleep disturbances and activity limitation. The similarity between the impact of diagnosed asthma and undiagnosed asthma like illness suggests that the overall social and economic burden of asthma may be higher than previously estimated. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:557 / 568
页数:12
相关论文
共 44 条
[21]  
LEUNG R, 1994, EUR RESPIR J, V7, P2046
[22]   Indoor risk factors for asthma and wheezing among Seattle school children [J].
Maier, WC ;
Arrighi, HM ;
Morray, B ;
Llewellyn, C ;
Redding, GJ .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 (02) :208-214
[23]  
MAIER WC, 1997, PHARMACOEPIDEMIOL S2, V6, pS83
[24]  
*NIAID TASK FORC, 1979, NIH PUBL
[25]  
NYSTAD W, 1995, EUR RESP J S19, V8, P2835
[26]   THE INTERRELATIONSHIP AMONG BRONCHIAL HYPERRESPONSIVENESS, THE DIAGNOSIS OF ASTHMA, AND ASTHMA SYMPTOMS [J].
PATTEMORE, PK ;
ASHER, MI ;
HARRISON, AC ;
MITCHELL, EA ;
REA, HH ;
STEWART, AW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (03) :549-554
[27]   CHANGING PREVALENCE OF ASTHMA IN AUSTRALIAN CHILDREN [J].
PEAT, JK ;
VANDENBERG, RH ;
GREEN, WF ;
MELLIS, CM ;
LEEDER, SR ;
WOOLCOCK, AJ .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6944) :1591-1596
[28]  
PERONI DG, 1995, EUR RESP J S19, V8, P2835
[29]  
PIZZICHINI MMM, 1995, EUR RESP J S19, V8, P2835
[30]   BRONCHIAL HYPERRESPONSIVENESS IN 2 POPULATIONS OF AUSTRALIAN SCHOOLCHILDREN .1. RELATION TO RESPIRATORY SYMPTOMS AND DIAGNOSED ASTHMA [J].
SALOME, CM ;
PEAT, JK ;
BRITTON, WJ ;
WOOLCOCK, AJ .
CLINICAL ALLERGY, 1987, 17 (04) :271-281